Related Experiment Videos
B cell tolerance to xenoantigens.
1Department of Surgery, Division of Frontier Medical Science, Programmes for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Xenotransplantation
|February 18, 2003
Summary
Pig-to-human xenotransplantation faces immune barriers, primarily natural antibodies targeting pig cells. Strategies focus on overcoming antibody-mediated rejection and inducing B-cell tolerance for successful organ transplantation.
Area of Science:
- Immunology
- Transplantation Biology
- Xenotransplantation Research
Background:
- The critical shortage of human donor organs drives research into xenotransplantation.
- Pig organs are a potential solution, but significant immunological barriers exist.
- Natural human antibodies against pig antigens cause hyperacute rejection, a major hurdle.
Purpose of the Study:
- To review B cell responses to xenoantigens.
- To explore strategies for inducing B cell tolerance in xenotransplantation.
- To address antibody-mediated rejection in pig-to-primate transplantation.
Main Methods:
- Review of current research on B cell properties and xenoantigen responses.
- Analysis of strategies to overcome antibody-mediated rejection, including antibody depletion and complement inhibition.
- Exploration of inducing xenogeneic hematopoietic chimerism for B cell tolerance.
Main Results:
- Natural antibodies (Abs) against Galalpha1-3Galbeta1-4GlcNAc epitopes are a primary barrier.
- Both hyperacute and acute vascular rejection are significant challenges.
- Various therapeutic strategies are being developed to mitigate immune responses.
Conclusions:
- Overcoming antibody-mediated rejection is crucial for successful xenotransplantation.
- Inducing B cell tolerance via xenogeneic hematopoietic chimerism offers a potential long-term solution.
- Further research into B cell properties and tolerance induction is essential.